drugset / Trial / NCT00369655

VEGF Trap in Treating Patients With Metastatic Breast Cancer

NCT00369655

Phase 2 Completed 21 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well VEGF Trap works in treating patients with metastatic breast cancer. VEGF Trap may stop the growth of tumor cells by blocking blood flow to the tumor

Timeline

Start
2007-01
Primary completion
2008-03
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aflibercept Protein / enzyme biologic Intravenous

Indications